Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Our 200+ faculty members from different schools and departments are dedicated to advancing the field of diabetes through cutting-edge research. In the ultimate search for a curative therapy for ...

after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...

Diabetic ketoacidosis (DKA) is a build-up of substances called ketones in the blood that can happen if a patient's blood glucose levels are too high for too long and is caused by a lack of insulin ...

Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its ...

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

May 14, 2025 — A new study shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not ...

Exercise improves functional outcomes in patients with diabetic cardiomyopathy (DiaCM). The molecular mechanism underlying cardiac benefits of exercise in DiaCM remains incompletely understood.

Ramazan Aygun and Mahmut Karakaya Kennesaw State University researchers Mahmut Karakaya and Ramazan Aygun recently earned a National Institutes of Health (NIH) grant to support their technology-driven ...

Approximately one in six people who are in the preliminary stages of type 2 diabetes will have a heart attack or stroke within eight years of getting the condition, the Telegraaf reports from a new ...